FULC Stock Analysis: Buy, Sell, or Hold?
FULC - Fulcrum Therapeutics, Inc. Common Stock
$3.74
0.03 (0.81%)
â˛
5d:
-3.86%
30d:
+6.86%
90d:
-47.4%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When FULC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: FULC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: FULC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: FULC is currently trading at $3.74, which is considered fair relative to its 30-day fair value range of $3.59 to $3.77.
Technical Outlook: Technically, FULC is in a strong downtrend. Immediate support is located at $3.54, while resistance sits at $3.91.
Market Sentiment: FULC scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FULC is in a strong downtrend. Immediate support is located at $3.54, while resistance sits at $3.91.
Market Sentiment: FULC scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.59 -
$3.77
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.1%
Protect Your Profits
Holding FULC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($3.40)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.59 -
$3.77
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.54
Resistance Level
$3.91
Current Trend
Strong Downtrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.67
Wall Street Target
$3.40
(-9.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 17, 2026 6:02 AM ET
Data refreshes hourly during market hours. Next update: 7:02 AM
Data refreshes hourly during market hours. Next update: 7:02 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FULC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 43 HOLD |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 60 BUY |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$834 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 53 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$131 | 42 HOLD |
Advanced FULC Option Strategies
Professional options setups generated by AI based on today's FULC price and gamma walls.
